|
|
 |
|
SHPGY: Shire Plc Ads - Stock News |
Enter Ticker:
|
|
| Nov 17, 2009 |
Zacks Bull and Bear of the Day Highlights: Sealed Air Corporation, Hologic, Inc., Genzyme Corp., Shire plc and Protalix BioTherapeutics Inc. |
| Nov 16, 2009 |
Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants |
| Nov 16, 2009 |
Shire (SHPGY) Downgrade Alert, Watch for 15.4% Technical Uptrend Reversal |
| Nov 16, 2009 |
Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants |
| Nov 16, 2009 |
Analyst Downgrades for November 16th |
| Nov 13, 2009 |
BiomedReports: News and FDA Updates for Shire plc (Nasdaq:SHPGY), ULURU (NYSE:ULU) |
| Nov 12, 2009 |
Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII |
| Nov 11, 2009 |
Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII |
| Nov 09, 2009 |
Shire Up 10.1% Since SmarTrend's Buy Recommendation |
| Nov 09, 2009 |
Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide |
| Nov 04, 2009 |
SHIRE PLC - FDA Grants Priority Review for Shire's velaglucerase |
| Nov 04, 2009 |
FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease |
| Nov 04, 2009 |
Porter Novelli Wins Gold from Medical Marketing & Media for Best Unbranded TV Ad |
| Nov 04, 2009 |
Shire Extends Agreement with Medidata Solutions for Trial Planning Products |
| Nov 04, 2009 |
FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease |
| |
| ZACKS COMMENTARY FOR SHPGY |
| Nov 19, 2009 | Zacks Blog: Genzyme’s Problems Continue | | Nov 17, 2009 | Zacks Blog: Zacks Bull and Bear of the Day Highlights: Sealed Air Corporation, Hologic, Inc., Genzyme Corp., Shire plc and Protalix BioTherapeutics Inc. | | Nov 16, 2009 | Zacks Blog: Contamination Issues Haunt GENZ | | Nov 13, 2009 | Zacks Equity Research: Report for SHPGY | | Oct 22, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: US Bancorp, Visa Inc., Genzyme Corp, Shire plc and Protalix BioTherapeutics Inc. | | Oct 21, 2009 | Zacks Blog: Genzyme Misses & Slashes | | Sep 24, 2009 | Zacks Blog: Genzyme Struggles to Restore Order | | Sep 23, 2009 | Zacks Blog: BioMarin Begins Mid-Stage Trial | | Sep 04, 2009 | Zacks Blog: Shire Receives FDA Approval | | Sep 02, 2009 | Zacks Blog: Shire Moving Up with Gaucher Drug | | Aug 26, 2009 | Zacks Blog: Another Blow for Genzyme | | Aug 25, 2009 | Zacks Blog: Shire Aims Big in HGT Segment |
|
|
Sponsored Links 
-0.17